La chimiokine CXCL12 et le papillomavirus humain - Une piste pour la pathogenèse du syndrome WHIM

Emilie Brotin; Laetitia Carthagena; Ken Y.C. Chow; Françoise Bachelerie

doi:10.1051/medsci/2011274002

Accueil

Tous les numéros

Volume 27 / Numéro 4 (Avril 2011)

Med Sci (Paris), 27 4 (2011) 341-343

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 27, Numéro 4, Avril 2011


Page(s)		341 - 343
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2011274002
Publié en ligne		28 avril 2011

KawaiT, MalechHL. WHIM syndrome : congenital immune deficiency disease. Curr Opin Hematol 2009 ; 16 : 20-26. [CrossRef] [PubMed] [Google Scholar]
HernandezPA, GorlinRJ, LukensJN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003 ; 34 : 70-74. [CrossRef] [PubMed] [Google Scholar]
DoorbarJ. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006 ; 110 : 525-541. [CrossRef] [PubMed] [Google Scholar]
BalabanianK, LaganeB, PablosJL, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 2005 ; 105 : 2449-2457. [CrossRef] [PubMed] [Google Scholar]
CiprianiNA, BlairE, TaxyJB. WHIM syndrome and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 ; 109 : 105-108. [CrossRef] [PubMed] [Google Scholar]
TassoneL, MorattoD, VermiW, et al. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 2010 ; 116 : 4870-4873. [CrossRef] [PubMed] [Google Scholar]
HandisuryaA, SchellenbacherC, ReiningerB, et al. A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome. Vaccine 2010 ; 28 : 4837-4841. [CrossRef] [PubMed] [Google Scholar]
FlorinL, Maas-SzabowskiN, WernerS, et al. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005 ; 118 : 1981-1989. [CrossRef] [PubMed] [Google Scholar]
ChowKY, BrotinÉ, Ben KhalifaY, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes : clues to understanding HPVpathogenesis in WHIM syndrome. Cell Host Microbe 2010 ; 8 : 523-533. [CrossRef] [PubMed] [Google Scholar]
ChapmanS, LiuX, MeyersC, et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010 ; 120 : 2619-2626. [CrossRef] [PubMed] [Google Scholar]
BignonA, BiajouxV, Bouchet-DelbosL, et al. CXCR4, une cible thérapeutique dans certains déficits immunitaires rares ?Med Sci (Paris) 2011 ; 27 : 391-397. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] KawaiT, MalechHL. WHIM syndrome : congenital immune deficiency disease. Curr Opin Hematol 2009 ; 16 : 20-26. [CrossRef] [PubMed] [Google Scholar]

[2] HernandezPA, GorlinRJ, LukensJN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003 ; 34 : 70-74. [CrossRef] [PubMed] [Google Scholar]

[3] DoorbarJ. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006 ; 110 : 525-541. [CrossRef] [PubMed] [Google Scholar]

[4] BalabanianK, LaganeB, PablosJL, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 2005 ; 105 : 2449-2457. [CrossRef] [PubMed] [Google Scholar]

[5] CiprianiNA, BlairE, TaxyJB. WHIM syndrome and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 ; 109 : 105-108. [CrossRef] [PubMed] [Google Scholar]

[6] TassoneL, MorattoD, VermiW, et al. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 2010 ; 116 : 4870-4873. [CrossRef] [PubMed] [Google Scholar]

[7] HandisuryaA, SchellenbacherC, ReiningerB, et al. A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome. Vaccine 2010 ; 28 : 4837-4841. [CrossRef] [PubMed] [Google Scholar]

[8] FlorinL, Maas-SzabowskiN, WernerS, et al. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005 ; 118 : 1981-1989. [CrossRef] [PubMed] [Google Scholar]

[9] ChowKY, BrotinÉ, Ben KhalifaY, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes : clues to understanding HPVpathogenesis in WHIM syndrome. Cell Host Microbe 2010 ; 8 : 523-533. [CrossRef] [PubMed] [Google Scholar]

[10] ChapmanS, LiuX, MeyersC, et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010 ; 120 : 2619-2626. [CrossRef] [PubMed] [Google Scholar]

[11] BignonA, BiajouxV, Bouchet-DelbosL, et al. CXCR4, une cible thérapeutique dans certains déficits immunitaires rares ?Med Sci (Paris) 2011 ; 27 : 391-397. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]